Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Aegerion Pharma Inc (AEGR)

Aegerion Pharma Inc (AEGR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 55,250
  • Shares Outstanding, K 29,540
  • Annual Sales, $ 239,890 K
  • Annual Income, $ -73,340 K
  • 60-Month Beta 0.50
  • Price/Sales 0.23
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -4.07
  • Most Recent Earnings -0.37 on 11/03/16
  • Next Earnings Date 11/14/16
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/16
See More
  • Average Estimate -0.33
  • Number of Estimates 2
  • High Estimate -0.16
  • Low Estimate -0.50
  • Prior Year -0.89
  • Growth Rate Est. (year over year) +62.92%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.50 +31.33%
on 11/07/16
2.34 -15.81%
on 11/29/16
+0.14 (+7.65%)
since 10/28/16
3-Month
1.50 +31.33%
on 11/07/16
3.35 -41.19%
on 09/29/16
+0.33 (+20.12%)
since 08/29/16
52-Week
1.23 +60.16%
on 06/14/16
10.85 -81.84%
on 12/24/15
-8.49 (-81.17%)
since 11/27/15

Most Recent Stories

More News
Berman Tabacco Announces Client Recovery in $6.5 Million Self-Litigated False Claims Act Settlement Involving Eight Former Executives and Employees of Aegerion Pharmaceuticals, Inc.

BOSTON, MA / ACCESSWIRE / December 20, 2019 / announces a $6.5 million settlement in a False Claims Act case brought against eight former executives and employees of Aegerion Pharmaceuticals, Inc. ("Aegerion"...

AEGR : 1.97 (+5.35%)
Novelion Therapeutics Announces Completion of Aegerion Transaction and Departure of Certain Directors and Officers

Novelion Therapeutics Inc. (NASDAQ: NVLN) ("Novelion" or the "Company"), announced that, further to its press release dated September 11, 2019, the acquisition by Amryt Pharma Plc ("Amryt") of 100% of...

AEGR : 1.97 (+5.35%)
NVLN : 0.68 (-3.34%)
Novelion Therapeutics Announces US Court Confirmation of Aegerion Bankruptcy Case, Update on Nasdaq Delisting and Date of Annual General Meeting of Shareholders

Novelion Therapeutics Inc. (NASDAQ: NVLN) ("Novelion" or the "Company"), announced that, further to its press release dated August 30, 2019, the United States Bankruptcy Court for the Southern District...

AEGR : 1.97 (+5.35%)
NVLN : 0.68 (-3.34%)
Novelion Therapeutics Announces Dismissal of Whitefort Capital Petition

Novelion Therapeutics Inc. (NASDAQ:NVLN), a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare metabolic diseases ("Novelion"), announced that on July...

AEGR : 1.97 (+5.35%)
NVLN : 0.68 (-3.34%)
DJ New Tax Law May Encourage Home Rentals

The new tax law brought welcome news for people who rent out their homes for short periods. And it likely will entice even more people to do it.

Novelion Therapeutics Observes World Lipodystrophy Day

Novelion Therapeutics Inc. (NASDAQ: NVLN), a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare diseases, in association with its subsidiary Aegerion...

AEGR : 1.97 (+5.35%)
NVLN : 0.68 (-3.34%)
Trade AEGR with:

Business Summary

Aegerion Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the development and commercialization of therapeutics to treat lipid disorders. Its products include Lomitapide and Implitapide. Lomitapide is a small molecule microsomal triglyceride transfer protein inhibitor, or MTP-I, that is...

See More

Key Turning Points

2nd Resistance Point 2.54
1st Resistance Point 2.25
Last Price 1.97
1st Support Level 1.77
2nd Support Level 1.58

See More

52-Week High 10.85
Fibonacci 61.8% 7.18
Fibonacci 50% 6.04
Fibonacci 38.2% 4.90
Last Price 1.97
52-Week Low 1.23

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar